Skip to main content

Table 6 Relationship between change in TSQM and change in CAMPHOR QoL score

From: Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

Predictor Model R 2 Standardized β ± SE p
Unadjusted Model
  Effectiveness 0.13 −0.07 ± 0.02 0.002
  Side effects <0.01 −0.01 ± 0.02 0.81
  Convenience 0.09 −0.05 ± 0.02 0.008
  Global satisfaction 0.06 −0.05 ± 0.02 0.03
Adjusted Model
  Effectiveness 0.12 −0.07 ± 0.02 0.002
  Side effects <0.01 −0.02 ± 0.03 0.50
  Convenience 0.08 −0.05 ± 0.02 0.01
  Global satisfaction 0.03 −0.04 ± 0.02 0.05
  1. Adjusted model includes age, sex, race, etiology of PAH, WHO functional class, and type of background therapy.